Citi analyst Nicholas Joseph downgraded Healthcare Realty Trust to Neutral from Buy with a price target of $22, down from $22.50. The analyst continues to believes that medical office real estate could hold up better in an economic downturn relative to other real estate subsectors, but he says internal growth upside remains limited and execution on external growth has become more challenged for Healthcare Realty.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on HR:
- Billionaire Steve Cohen Goes Big on These 2 High-Yield Dividend Stocks
- Healthcare Realty Trust reports Q3 normalized FFO 39c, consensus 42c
- Healthcare Realty Trust Reports Results for the Third Quarter
- Healthcare Realty Trust Announces Quarterly Dividend
- Healthcare Realty Trust Releases Its Fourth Annual Corporate Responsibility Report and 2022 GRESB Assessment Rankings